2 -glycoprotein I (  2 -GPI) is a major antigen for antiphospholipid antibodies (Abs, aPL) present in patients with antiphospholipid syndrome (APS). We recently reported ( J. Lipid Res ., 42: 697, 2001; J. Lipid Res. , 43: 1486, 2002) that  2 -GPI specifically binds to Cu 2 ؉ -oxidized LDL (oxLDL) and that the  2 -GPI ligands are -carboxylated 7-ketocholesteryl esters. In the present study, we demonstrate that oxLDL forms stable and nondissociable complexes with  2 -GPI in serum, and that high serum levels of the complexes are associated with arterial thrombosis in APS. A conjugated ketone function at the 7-position of cholesterol as well as the -carboxyl function of the  2 -GPI ligands was necessary for  2 -GPI binding. The ligand-mediated noncovalent interaction of  2 -GPI and oxLDL undergoes a temperature-and time-dependent conversion to much more stable but readily dissociable complexes in vitro at neutral pH. In contrast, stable and nondissociable  2 -GPI-oxLDL complexes were frequently detected in sera from patients with APS and/or systemic lupus erythematodes. Both the presence of  2 -GPI-oxLDL complexes and IgG Abs recognizing these complexes were strongly associated with arterial thrombosis. Further, these same Abs correlated with IgG immune complexes containing  2 -GPI or LDL. Thus, the  2 -GPI-oxLDL complexes acting as an autoantigen are closely associated with autoimmune-mediated atherogene-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.